- Home
- BLDE vs GEVO Comparison
BLDE vs GEVO Comparison
Compare BLDE & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- GEVO
- Stock Information
- Founded
- BLDE 2014
- GEVO 2005
- Country
- BLDE United States
- GEVO United States
- Employees
- BLDE N/A
- GEVO N/A
- Industry
- BLDE Aerospace
- GEVO Major Chemicals
- Sector
- BLDE Consumer Discretionary
- GEVO Industrials
- Exchange
- BLDE Nasdaq
- GEVO Nasdaq
- Market Cap
- BLDE 286.0M
- GEVO 246.8M
- IPO Year
- BLDE N/A
- GEVO 2011
- Fundamental
- Price
- BLDE $3.59
- GEVO $1.14
- Analyst Decision
- BLDE Strong Buy
- GEVO Buy
- Analyst Count
- BLDE 2
- GEVO 2
- Target Price
- BLDE $6.25
- GEVO $7.58
- AVG Volume (30 Days)
- BLDE 623.3K
- GEVO 3.4M
- Earning Date
- BLDE 05-12-2025
- GEVO 05-13-2025
- Dividend Yield
- BLDE N/A
- GEVO N/A
- EPS Growth
- BLDE N/A
- GEVO N/A
- EPS
- BLDE N/A
- GEVO N/A
- Revenue
- BLDE $251,485,000.00
- GEVO $42,034,000.00
- Revenue This Year
- BLDE $5.58
- GEVO $631.78
- Revenue Next Year
- BLDE $8.40
- GEVO $80.71
- P/E Ratio
- BLDE N/A
- GEVO N/A
- Revenue Growth
- BLDE 8.67
- GEVO 145.38
- 52 Week Low
- BLDE $2.35
- GEVO $0.48
- 52 Week High
- BLDE $5.17
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- BLDE 62.53
- GEVO 47.89
- Support Level
- BLDE $3.40
- GEVO $1.00
- Resistance Level
- BLDE $3.84
- GEVO $1.23
- Average True Range (ATR)
- BLDE 0.16
- GEVO 0.08
- MACD
- BLDE -0.00
- GEVO 0.00
- Stochastic Oscillator
- BLDE 52.93
- GEVO 21.87
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.